Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...

The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Willard Police Chief Tom McClain has been in law enforcement for many decades, and has been the leader of Willard’s police force since 1993. He’s fought crime for years, ...

Discover how weather conditions affect idiopathic pulmonary fibrosis (IPF) symptoms and learn practical tips to manage your ...

New research identifies a specific monocyte gene signature that predicts mortality in IPF, offering potential targets ...

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...

"I have always hoped that we would be able to keep the disease in check with medication, and the development has actually ...

If you have scarring in your lungs, you may have been diagnosed with pulmonary fibrosis. When the reason for this scarring is unknown, your condition is called idiopathic pulmonary fibrosis (IPF). You ...

The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...